Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-α following subarachnoid hemorrhage

Journal of Neurosurgery

Volumn 87, Issue 2, 1997, Pages 215-220

  Mathieson, Tiit ^a   Edner, Göran ^b   Ulfarsson, Elfar ^b   Andersson, Birger ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Inflammation; Interleukin 1; Ischemia; Subarachnoid hemorrhage; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

EID: 0030833671     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.2.0215     Document Type: Article

References (48)

1. Beamer NB, Coull BM, Clark WM, et al: Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 37:800-804, 1995
2. Borgerding RA, Murphy S: Expression of inducible nitric oxide synthase in cerebral endothelial cells is regulated by cytokine-activated astrocytes. J Neurochem 65:1342-1347, 1995
3. 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumor necrosis factor-α and lipopolysaccharide. Brain Res 543:194-200, 1991
4. Buttini M, Appel K, Sauter A, et al: Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 71:1-16, 1996
5. Buttini M, Boddeke HWHM: Peripheral lipopolysaccharide stimulation induces interleukin-1β messenger RNA in rat brain microglial cells. Neuroscience 65:523-530, 1995
6. Dinarello CA: Modalities for reducing interleukin 1 activity in disease. Immunol Today 14:260-264, 1993
7. Dinarello CA: An update on human interleukin 1: from molecular biology to clinical relevance. J Clin Immunol 5:287-297, 1989
8. Ecker A, Riemenschneider PA: Arteriographic demonstration of spasm of the intracranial arteries. With special reference to saccular arterial aneurysms. J Neurosurg 8:660-667, 1951
9. Engervall P, Andersson B, Björkholm M: Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br J Haematol 91:838-845, 1995
10. Feuerstein GZ, Liu T, Barone FC: Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev 6:341-360, 1994
11. Findlay JM, Macdonald RL, Weir BKA: Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal SAH. Cerebrovasc Brain Metab Rev 3:336-361, 1991
12. Fisher M, Plante GM, Doyle EM: Inhibition of inflammatory cell-mediated myelin oxidation and interleukin-1 beta generation by a 21-aminosteroid, U74500A. J Neurol Sci 119:189-194, 1993
13. Giulian D, Corpuz M, Chapman S, et al: Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J Neurosci Res 36:681-693, 1993
14. Giulian D, Robertson C: Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 27:33-42, 1990
15. Holmin S, Schalling M, Höjeberg B, et al: Delayed cytokine expression in rat brain following experimental contusion. J Neurosurg 86:493-504, 1997
16. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system I: expression and recognition. Trends Neurosci 18:83-88, 1995
17. Hunt WE, Hess RM: Surgical risks as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14-20, 1968
18. 2 and vasospasm in patients with subarachnoid hemorrhage: is vasospasm the actual cause of reduced cerebral uptake of oxygen? J Cereb Blood Flow Metab 7 (Suppl 1):S660, 1987 (Abstract)
19. Jennett B, Teasdale G: Management of Head Injuries. Philadelphia: FA Davis, 1981
20. Kassell NF, Haley EC Jr, Apperson-Hansen C, et al: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996
21. Kim KS, Wass CA, Cross AS, et al: Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res 11:293-298, 1992
22. Lees GJ: The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci 114:119-122, 1993
23. Liu T, Clark RK, McDonnell PC, et al: Tumor necrosis factor-α expression in ischemic neurons. Stroke 25:1481-1488, 1994
24. Liu T, McDonnell PC, Young PR, et al: Interleukin-1β mRNA expression in ischemic rat cortex. Stroke 24:1746-1751, 1993
25. Maiuri F, Gallicchio B, Donati P, et al: The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage. J Neurosurg Sci 31:45-48, 1988
26. Marzatico F, Gaetani P, Silvani V, et al: Experimental isobaric subarachnoid hemorrhage: regional mitochondrial function during the acute and late phase. Surg Neurol 34:294-300, 1990
27. Mathiesen T, Andersson B, Loftenius A, et al: Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 78:562-567, 1993
28. Mathiesen T, Fuchs D, Wachter H, et al: Increased CSF neopterin levels in subarachnoid hemorrhage. J Neurosurg 73:69-71, 1990
29. Mathiesen T, Lefvert AK: Cerebrospinal fluid and blood lymphocyte subpopulations following subarachnoid haemorrhage. Br J Neurosurg 10:89-92, 1996
30. Morimoto A, Watanabe T, Sakata Y, et al: Leukocytosis induced by microinjection of endogenous pyrogen or interleukin-1 into the preoptic and anterior hypothalamus. Brain Res 475:345-348, 1988
31. Neil-Dwyer G, Cruickshank J: The blood leucocyte count and its prognostic significance in subarachnoid haemorrhage. Brain 97:79-86, 1974
32. Pellettieri L, Nilsson B, Carlsson CA, et al: Serum immunocomplexes in patients with subarachnoid hemorrhage. Neurosurgery 19:767-771, 1986
33. Persson L, Hillered L: Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J Neurosurg 76:72-80, 1992
34. Peterson JW, Kwun BD, Hackett JD, et al: The role of inflammation in experimental cerebral vasospasm. J Neurosurg 72:767-774, 1990
35. Peterson JW, Kwun BD, Teramura A, et al: Immunological reaction against the aging human subarachnoid erythrocyte. A model for the onset of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 71:718-726, 1989
36. Rothwell NJ: Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol Sci 12:430-436, 1991
37. Selmaj KW, Farooq M, Norton WT, et al: Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 144:129-135, 1990
38. Selmaj KW, Raine CS: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346, 1988
39. Suzuki S, Takenaka K, Kassell NF, et al: Hemoglobin augmentation of interleukin-1β-induced production of nitric oxide in smooth-muscle cells. J Neurosurg 81:895-901, 1994
40. Svendgaard NA, Arbab MA, Delgado TJ, et al: Effect of selective lesions of medullary cathecholamine nuclei on experimental cerebral vasospasm in the rat. J Cereb Blood Flow Metab 7:21-28, 1987
41. Tchelingerian JL, Quinonero J, Booss J, et al: Localization of TNF-α and IL-1α immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 10:213-224, 1993
42. Waage A, Halstensen A, Shalaby P, et al: Local production of tumor necrosis factor α, interleukin 1 and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 170:1859-1867, 1989
43. Walton JN: Subarachnoid Hemorrhage. Edinburgh: ES Livingstone, 1956
44. Weir B, Disney L, Grace M, et al: Daily trends in white blood cell count and temperature after subarachnoidal hemorrhage from aneurysm. Neurosurgery 25:161-165, 1989
45. Weir B, Grace M, Hansen J, et al: Time course of vasospasm in man. J Neurosurg 48:173-178, 1978
46. Wilkins RH: Cerebral vasospasm. Crit Rev Neurobiol 6:51-77, 1990
47. Woodroofe MN, Sarna GS, Wadhwa M, et al: Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol 33:227-236, 1991
48. Yabuuchi K, Minami M, Katsumata S, et al: An in situ hybridization study on interleukin-1 beta mRNA induced by transient forebrain ischemia in the rat brain. Mol Brain Res 26:135-142, 1994